TrueNorth acted as exclusive M&A advisor to Calvert Holdings on its sale of Calvert Laboratories to Altasciences, a CRO/CDMO and portfolio company of Novo Holdings. Calvert and Altasciences have strategically complementary markets, capabilities, expertise and values, which will enhance opportunities to provide a comprehensive, fully integrated early phase drug development solution, while addressing the ever-changing outsourcing challenges of biopharmaceutical companies across the globe.